Public Relations  >  News Center  >  News Releases  >  May 2019  >  May 6, 2019  >  Creighton’s Lynch named a ‘Giant of Cancer Care’
Creighton’s Lynch named a ‘Giant of Cancer Care’

Henry T. Lynch, MDCreighton University School of Medicine professor and eminent cancer researcher Henry T. Lynch, MD, will be honored later this month with one of 15 2019 Giants of Cancer Care awards from OncLive, a digital platform of resources for practicing oncologists with a suite of internationally recognized publications.

Lynch, founder and director of the Hereditary Cancer Center at Creighton, has dedicated his life to cancer research, especially hereditary cancers, a field he helped found and for which his name now stands as a testament. Lynch syndrome, which demonstrates the hereditariness of some cancers, was officially recognized in the 1980s.

OncLive is recognizing Lynch’s lifetime of research in genetics and cancer prevention. Honorees will be recognized during the seventh annual Giants of Cancer Care Winners’ Reception on May 30 at the Adler Planetarium in Chicago.

“We are looking forward to honoring each of these outstanding individuals at this year’s Giants of Cancer Care celebration,” said Michael J. Hennessy Jr., president of MJH Associates, parent company of OncLive. “Each inductee has worked hard to propel the field of oncology forward through groundbreaking and innovative contributions in cancer treatment, diagnosis, and research.”

Nominated by the oncology community, all finalists for the Giants of Cancer Care award are selected by a seven-member advisory board of world-renowned oncologists. The finalists in each category are then voted on by a 115-plus member selection committee comprising world leading physicians in the oncology space.

Awardees are selected in 15 categories: breast cancer; cancer diagnosis; community outreach, education and/or cancer policy; gastrointestinal cancer; genitourinary cancer; gynecologic malignancies; leukemia; lung cancer; lymphoma; melanoma and other skin cancers; myeloma; pediatric oncology; prevention/genetics, supportive, palliative and/or geriatric care, and translational science.

---
Creighton University is a Jesuit, Catholic university bridging health, law, business and the arts and sciences for a more just world.